Family Medicine Governments Medical Specialties News WHO

WHO will decide on its hydroxychloroquine trial suspension in 24 hours

The World Health Organization (WHO) should have enough information in 24 hours to decide whether to continue suspending its trial of hydroxychloroquine for use against coronavirus, its chief scientist Soumya Swaminathan said on Monday.

Her comments come a week after the UN body paused its large study of the anti-malarial drug to treat COVID-19 due to concerns it increased death rates and irregular heartbeats in patients.

The move prompted several European governments to ban the use of the drug, also used to treat rheumatoid arthritis and lupus and promoted by U.S. President Donald Trump to help combat the disease.

Sanofi on Friday temporarily stopped recruiting new COVID-19 patients for its two clinical trials of the drug and said it would no longer supply it to treat COVID-19 until safety concerns are cleared up.

Read More

Meeta Ramnani
Meeta Ramnani
Meeta develops credible content about various markets based on deep research, opinions from experts and inputs from industry leaders. As the managing editor at Smart Industry News, she assures that every piece of news and article adds to the knowledge of decision makers. An avid bike rider, Meeta, is a postgraduate from Indian Institute of Journalism and New Media (IIJNM) Bangalore, where her specialization was Business Journalism. She carries experience from mainstream print media including The Times Group and Sakal Media Group.